TY  - GEN
AU  - Agus,David B
AU  - Gordon,Michael S
AU  - Taylor,Charles
AU  - Natale,Ronald B
AU  - Karlan,Beth
AU  - Mendelson,David S
AU  - Press,Michael F
AU  - Allison,David E
AU  - Sliwkowski,Mark X
AU  - Lieberman,Gracie
AU  - Kelsey,Stephen M
AU  - Fyfe,Gwen
TI  - Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancer
SN  - 0732-183X
PY  - 2005///0505
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Breast Neoplasms
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Infusions, Intravenous
KW  - Male
KW  - Middle Aged
KW  - Neoplasms
KW  - drug therapy
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1200/JCO.2005.03.184
ER  -